Results 121 to 130 of about 830 (135)
Some of the next articles are maybe not open access.
Effects of pentadecapeptide BPC-157 on rat calvarial bicortical defects
2003Gastric pentadecapeptide BPC-157 (currently in clinical phase II for inflammatory bowel disease) was tested in 7 mm diameter surgically created defects of rat calvaria. Insufficient or absence of bone healing is a frequent problem within all surgical fields.
Dobric, Ivan +16 more
openaire +2 more sources
Pentadecapeptide BPC 157 and Rac 1 inhibitors
2016UVOD: Rac1 je mali signalizirajući G-protein koji može aktivirati NF-kappaB. Pentadekapeptid BPC 157 smanjuje transkripciju Vcam-1 u NF-kappaB signalnom putu kao i neki NF-kappaB inhibitori te suprimira da ERK inducira Vcam-1 preko NF-kappaB aktivacije.
openaire
Beneficial effect of BPC-157 on cardiovascular stress
2016U radu se opisuju učinci pentadekapeptida BPC 157 na razne modele stresa u kardiovaskularnim eksperimentalnim modelima.
openaire +1 more source
Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation
European Journal of Pharmacology, 2019Marijana Coric +2 more
exaly
The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks
Journal of Physiology (Paris), 1997Predrag Sikiric +2 more
exaly
Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H
Drug Testing and Analysis, 2017Holly Cox
exaly

